Summary

The global market for Coagulation POCT was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Coagulation POCT, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Coagulation POCT by region & country, by Type, and by Application.
The Coagulation POCT market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Coagulation POCT.

Market Segmentation
By Company
Sysmex Corporation
Abbott
Micropoint Biotechnologies Co., Ltd
Beijing Succeeder Technology Inc.
Werfen
Stago
Helena Biosciences
Maccura Biotechnology Co
PZ Cormay
Medtronic
BPC BioSed
Roche
Shenzhen Ultra-Diagnostics Biotec. Co.,Ltd.
Guangzhou Wondfo Biotech Co.,Ltd
Getein Biotech, Inc.
URIT Medical Electronic
Rayto Life and Analytical Sciences
Segment by Type
Based on Electrochemical
Based on Microfluidics
Other
Segment by Application
Prothrombin Time (PT)
Fibrinogen
Antithrombin
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Coagulation POCT manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Coagulation POCT in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Coagulation POCT in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

ページTOPに戻る

Table of Contents

1 Market Overview
1.1 Coagulation POCT Product Introduction
1.2 Global Coagulation POCT Market Size Forecast
1.2.1 Global Coagulation POCT Sales Value (2020-2031)
1.2.2 Global Coagulation POCT Sales Volume (2020-2031)
1.2.3 Global Coagulation POCT Sales Price (2020-2031)
1.3 Coagulation POCT Market Trends & Drivers
1.3.1 Coagulation POCT Industry Trends
1.3.2 Coagulation POCT Market Drivers & Opportunity
1.3.3 Coagulation POCT Market Challenges
1.3.4 Coagulation POCT Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Coagulation POCT Players Revenue Ranking (2024)
2.2 Global Coagulation POCT Revenue by Company (2020-2025)
2.3 Global Coagulation POCT Players Sales Volume Ranking (2024)
2.4 Global Coagulation POCT Sales Volume by Company Players (2020-2025)
2.5 Global Coagulation POCT Average Price by Company (2020-2025)
2.6 Key Manufacturers Coagulation POCT Manufacturing Base and Headquarters
2.7 Key Manufacturers Coagulation POCT Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Coagulation POCT
2.9 Coagulation POCT Market Competitive Analysis
2.9.1 Coagulation POCT Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Coagulation POCT Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coagulation POCT as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Based on Electrochemical
3.1.2 Based on Microfluidics
3.1.3 Other
3.2 Global Coagulation POCT Sales Value by Type
3.2.1 Global Coagulation POCT Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Coagulation POCT Sales Value, by Type (2020-2031)
3.2.3 Global Coagulation POCT Sales Value, by Type (%) (2020-2031)
3.3 Global Coagulation POCT Sales Volume by Type
3.3.1 Global Coagulation POCT Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Coagulation POCT Sales Volume, by Type (2020-2031)
3.3.3 Global Coagulation POCT Sales Volume, by Type (%) (2020-2031)
3.4 Global Coagulation POCT Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Prothrombin Time (PT)
4.1.2 Fibrinogen
4.1.3 Antithrombin
4.1.4 Others
4.2 Global Coagulation POCT Sales Value by Application
4.2.1 Global Coagulation POCT Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Coagulation POCT Sales Value, by Application (2020-2031)
4.2.3 Global Coagulation POCT Sales Value, by Application (%) (2020-2031)
4.3 Global Coagulation POCT Sales Volume by Application
4.3.1 Global Coagulation POCT Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Coagulation POCT Sales Volume, by Application (2020-2031)
4.3.3 Global Coagulation POCT Sales Volume, by Application (%) (2020-2031)
4.4 Global Coagulation POCT Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Coagulation POCT Sales Value by Region
5.1.1 Global Coagulation POCT Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Coagulation POCT Sales Value by Region (2020-2025)
5.1.3 Global Coagulation POCT Sales Value by Region (2026-2031)
5.1.4 Global Coagulation POCT Sales Value by Region (%), (2020-2031)
5.2 Global Coagulation POCT Sales Volume by Region
5.2.1 Global Coagulation POCT Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Coagulation POCT Sales Volume by Region (2020-2025)
5.2.3 Global Coagulation POCT Sales Volume by Region (2026-2031)
5.2.4 Global Coagulation POCT Sales Volume by Region (%), (2020-2031)
5.3 Global Coagulation POCT Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Coagulation POCT Sales Value, 2020-2031
5.4.2 North America Coagulation POCT Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Coagulation POCT Sales Value, 2020-2031
5.5.2 Europe Coagulation POCT Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Coagulation POCT Sales Value, 2020-2031
5.6.2 Asia Pacific Coagulation POCT Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Coagulation POCT Sales Value, 2020-2031
5.7.2 South America Coagulation POCT Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Coagulation POCT Sales Value, 2020-2031
5.8.2 Middle East & Africa Coagulation POCT Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Coagulation POCT Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Coagulation POCT Sales Value
6.2.1 Key Countries/Regions Coagulation POCT Sales Value, 2020-2031
6.2.2 Key Countries/Regions Coagulation POCT Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Coagulation POCT Sales Value, 2020-2031
6.3.2 United States Coagulation POCT Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Coagulation POCT Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Coagulation POCT Sales Value, 2020-2031
6.4.2 Europe Coagulation POCT Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Coagulation POCT Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Coagulation POCT Sales Value, 2020-2031
6.5.2 China Coagulation POCT Sales Value by Type (%), 2024 VS 2031
6.5.3 China Coagulation POCT Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Coagulation POCT Sales Value, 2020-2031
6.6.2 Japan Coagulation POCT Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Coagulation POCT Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Coagulation POCT Sales Value, 2020-2031
6.7.2 South Korea Coagulation POCT Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Coagulation POCT Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Coagulation POCT Sales Value, 2020-2031
6.8.2 Southeast Asia Coagulation POCT Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Coagulation POCT Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Coagulation POCT Sales Value, 2020-2031
6.9.2 India Coagulation POCT Sales Value by Type (%), 2024 VS 2031
6.9.3 India Coagulation POCT Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Sysmex Corporation
7.1.1 Sysmex Corporation Company Information
7.1.2 Sysmex Corporation Introduction and Business Overview
7.1.3 Sysmex Corporation Coagulation POCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Sysmex Corporation Coagulation POCT Product Offerings
7.1.5 Sysmex Corporation Recent Development
7.2 Abbott
7.2.1 Abbott Company Information
7.2.2 Abbott Introduction and Business Overview
7.2.3 Abbott Coagulation POCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Abbott Coagulation POCT Product Offerings
7.2.5 Abbott Recent Development
7.3 Micropoint Biotechnologies Co., Ltd
7.3.1 Micropoint Biotechnologies Co., Ltd Company Information
7.3.2 Micropoint Biotechnologies Co., Ltd Introduction and Business Overview
7.3.3 Micropoint Biotechnologies Co., Ltd Coagulation POCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Micropoint Biotechnologies Co., Ltd Coagulation POCT Product Offerings
7.3.5 Micropoint Biotechnologies Co., Ltd Recent Development
7.4 Beijing Succeeder Technology Inc.
7.4.1 Beijing Succeeder Technology Inc. Company Information
7.4.2 Beijing Succeeder Technology Inc. Introduction and Business Overview
7.4.3 Beijing Succeeder Technology Inc. Coagulation POCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Beijing Succeeder Technology Inc. Coagulation POCT Product Offerings
7.4.5 Beijing Succeeder Technology Inc. Recent Development
7.5 Werfen
7.5.1 Werfen Company Information
7.5.2 Werfen Introduction and Business Overview
7.5.3 Werfen Coagulation POCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Werfen Coagulation POCT Product Offerings
7.5.5 Werfen Recent Development
7.6 Stago
7.6.1 Stago Company Information
7.6.2 Stago Introduction and Business Overview
7.6.3 Stago Coagulation POCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Stago Coagulation POCT Product Offerings
7.6.5 Stago Recent Development
7.7 Helena Biosciences
7.7.1 Helena Biosciences Company Information
7.7.2 Helena Biosciences Introduction and Business Overview
7.7.3 Helena Biosciences Coagulation POCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Helena Biosciences Coagulation POCT Product Offerings
7.7.5 Helena Biosciences Recent Development
7.8 Maccura Biotechnology Co
7.8.1 Maccura Biotechnology Co Company Information
7.8.2 Maccura Biotechnology Co Introduction and Business Overview
7.8.3 Maccura Biotechnology Co Coagulation POCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Maccura Biotechnology Co Coagulation POCT Product Offerings
7.8.5 Maccura Biotechnology Co Recent Development
7.9 PZ Cormay
7.9.1 PZ Cormay Company Information
7.9.2 PZ Cormay Introduction and Business Overview
7.9.3 PZ Cormay Coagulation POCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 PZ Cormay Coagulation POCT Product Offerings
7.9.5 PZ Cormay Recent Development
7.10 Medtronic
7.10.1 Medtronic Company Information
7.10.2 Medtronic Introduction and Business Overview
7.10.3 Medtronic Coagulation POCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Medtronic Coagulation POCT Product Offerings
7.10.5 Medtronic Recent Development
7.11 BPC BioSed
7.11.1 BPC BioSed Company Information
7.11.2 BPC BioSed Introduction and Business Overview
7.11.3 BPC BioSed Coagulation POCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 BPC BioSed Coagulation POCT Product Offerings
7.11.5 BPC BioSed Recent Development
7.12 Roche
7.12.1 Roche Company Information
7.12.2 Roche Introduction and Business Overview
7.12.3 Roche Coagulation POCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Roche Coagulation POCT Product Offerings
7.12.5 Roche Recent Development
7.13 Shenzhen Ultra-Diagnostics Biotec. Co.,Ltd.
7.13.1 Shenzhen Ultra-Diagnostics Biotec. Co.,Ltd. Company Information
7.13.2 Shenzhen Ultra-Diagnostics Biotec. Co.,Ltd. Introduction and Business Overview
7.13.3 Shenzhen Ultra-Diagnostics Biotec. Co.,Ltd. Coagulation POCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Shenzhen Ultra-Diagnostics Biotec. Co.,Ltd. Coagulation POCT Product Offerings
7.13.5 Shenzhen Ultra-Diagnostics Biotec. Co.,Ltd. Recent Development
7.14 Guangzhou Wondfo Biotech Co.,Ltd
7.14.1 Guangzhou Wondfo Biotech Co.,Ltd Company Information
7.14.2 Guangzhou Wondfo Biotech Co.,Ltd Introduction and Business Overview
7.14.3 Guangzhou Wondfo Biotech Co.,Ltd Coagulation POCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Guangzhou Wondfo Biotech Co.,Ltd Coagulation POCT Product Offerings
7.14.5 Guangzhou Wondfo Biotech Co.,Ltd Recent Development
7.15 Getein Biotech, Inc.
7.15.1 Getein Biotech, Inc. Company Information
7.15.2 Getein Biotech, Inc. Introduction and Business Overview
7.15.3 Getein Biotech, Inc. Coagulation POCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 Getein Biotech, Inc. Coagulation POCT Product Offerings
7.15.5 Getein Biotech, Inc. Recent Development
7.16 URIT Medical Electronic
7.16.1 URIT Medical Electronic Company Information
7.16.2 URIT Medical Electronic Introduction and Business Overview
7.16.3 URIT Medical Electronic Coagulation POCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 URIT Medical Electronic Coagulation POCT Product Offerings
7.16.5 URIT Medical Electronic Recent Development
7.17 Rayto Life and Analytical Sciences
7.17.1 Rayto Life and Analytical Sciences Company Information
7.17.2 Rayto Life and Analytical Sciences Introduction and Business Overview
7.17.3 Rayto Life and Analytical Sciences Coagulation POCT Sales, Revenue, Price and Gross Margin (2020-2025)
7.17.4 Rayto Life and Analytical Sciences Coagulation POCT Product Offerings
7.17.5 Rayto Life and Analytical Sciences Recent Development
8 Industry Chain Analysis
8.1 Coagulation POCT Industrial Chain
8.2 Coagulation POCT Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Coagulation POCT Sales Model
8.5.2 Sales Channel
8.5.3 Coagulation POCT Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer